Advisory Committees
-
May 14-15, 2009: Cellular, Tissue and Gene Therapies Advisory Committee Briefing Information
-
Topic 1
- May 14-15, 2009: Cellular, Tissue and Gene Therapies Advisory Committee Meeting Briefing Information: Topic 1 - Potential for Chlamydia trachomatis and Neisseria gonorrhoeae transmission by human cells, tissues, and cellular and tissue-based products (HCT/Ps) that are recovered from the reproductive system, gestational tissues, or other sources (PDF - 236KB)
- May 14-15, 2009: Cellular, Tissue and Gene Therapies Advisory Committee Meeting Briefing Information: Topic 1 - Bibliography (PDF - 69KB)
-
-
Topic 2
- May 14-15, 2009: Cellular, Tissue and Gene Therapies Advisory Committee Meeting Briefing Document: Topic 2 - Animal Models for Porcine Xenotransplantation Products Intended to Treat Type 1 Diabetes or Acute Liver Failure (PDF - 107KB)
Animal Models for Porcine Xenotransplantation Products Intended to Treat Type 1 Diabetes or Acute Liver Failure - May 14-15, 2009: Cellular, Tissue and Gene Therapies Advisory Committee Meeting Briefing Information: Topic 2 - Bibliography (PDF - 68KB)
-
-
Topic 3
- May 14-15, 2009: Cellular, Tissue and Gene Therapies Advisory Committee Meeting Briefing Information: Briefing Document and Questions to AC Panel (PDF - 1.5MB)
Clinical issues related to the FDA draft guidance “Preparation of IDEs and INDs for Products Intended to Repair or Replace Knee Cartilage” May 15, 2009: Cellular, Tissue and Gene Therapies Advisory Committee Meeting Presentation: Background Comments, Question 1, Topic III - Clinical issues related to the FDA draft guidance "Preparation of IDEs and INDs for Products Intended to Repair or Replace Knee Cartilage" (PPT - 89KB)
Brent A. Blumenstein, PhD
-
-
-







